Valeant, Ackman To Go Hostile As Allergan Spurns $53B Bid
Allergan Inc. said Tuesday that a sweetened $53 billion offer from Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman undershoots its true value and invites uncertainty, spurring plans for a...To view the full article, register now.
Already a subscriber? Click here to view full article